Results 191 to 200 of about 25,531,432 (247)

Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs.
Nathan M. Money   +5 more
wiley   +1 more source

Clinical progress note: Mumps

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Mumps was a common childhood viral illness before the implementation of the measles, mumps, and rubella (MMR) vaccination in 1967. There was a significant decrease in mumps cases in the postvaccine era; however, there has been an increase in outbreaks in the United States over the past two decades.
Sarah Ludvigsen, Mati Segev
wiley   +1 more source

Radiography students' knowledge, attitude and practice relating to infection prevention and control in the use of contrast media injectors in computed tomography

open access: yesJournal of Medical Radiation Sciences, Volume 72, Issue 1, Page 42-53, March 2025.
The aim of this study was to explore radiography students' knowledge, attitudes, and practice (KAP) relating to infection prevention and control (IPC) in the use of contrast media injectors in the computed tomography (CT) setting. Radiography students demonstrate varied comprehension of IPC regarding contrast media equipment within CT environment, and ...
Dania Abu Awwad   +4 more
wiley   +1 more source

Probiotics and intestinal permeability in adults with metabolic dysfunction‐associated steatohepatitis: A secondary analysis of a randomized clinical trial

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with altered intestinal permeability, allowing microbial products to translocate to the liver via the enterohepatic circulation and contributes to disease progression. The aim of our study was to evaluate the association between probiotic supplementation and serum
Bruna Concheski de Moura   +10 more
wiley   +1 more source

Absence of progressive liver disease after treatment in children with chronic hepatitis C: A nationwide registry study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives In adults with chronic hepatitis C (CHC) and advanced fibrosis, hepatocellular carcinoma (HCC) surveillance is recommended after achieving a sustained virologic response (SVR). However, post‐SVR surveillance strategies for children remain unclear. The aim of this study was to assess the durability of SVR and determine an appropriate
Hitoshi Tajiri   +6 more
wiley   +1 more source

Chronic conditions associated with paediatric onset inflammatory bowel diseases: A population‐based study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Several conditions are associated with inflammatory bowel disease (IBD), including immune‐mediated inflammatory diseases (IMIDs), extraintestinal manifestations (EIMs), and psychiatric disorders. This study aimed to describe at population‐level the comorbidities and their relative burden in paediatric‐onset IBD (pIBD).
Nicolas Richard   +480 more
wiley   +1 more source

Fecal microbiota transplantation and microbiota‐based therapeutics in pediatric clinical practice: Current status and emerging indications

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Fecal microbiota transplantation (FMT) is a safe and effective treatment for recurrent or refractory Clostridioides difficile infection (rCDI) in children and adults. This review outlines the evidence behind FMT for rCDI, considerations in special pediatric populations, and limitations in current practice due to FMT access for patients under ...
Nikhil Pai   +3 more
wiley   +1 more source

Higher incidence of paediatric autoimmune liver disease post‐COVID

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives A higher incidence of autoimmune conditions with greater disease severity is reported post‐Coronavirus Disease (COVID). The incidence and disease severity of paediatric autoimmune liver disease (AILD) post‐COVID has not been assessed.
Suz Warner   +6 more
wiley   +1 more source

Treatment of pediatric autoimmune liver disease beyond prednisolone and azathioprine in a cohort of 115 patients

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric autoimmune hepatitis (pAIH) is an acute or chronic inflammatory liver disease, caused by a dysregulation of the immune system. Autoimmune sclerosing cholangitis (ASC) additionally affects the bile ducts. Traditional first‐line treatment (FLT) consists of prednisolone and azathioprine.
Marie Korell   +10 more
wiley   +1 more source

A preterm neonate with infantile liver failure syndrome 1 due to leucyl‐tRNA synthetase 1 gene (LARS1) mutations with a histopathologic phenotype of neonatal hemochromatosis

open access: yesJPGN Reports, EarlyView.
Abstract We report a case of a premature, growth‐restricted female infant with feeding intolerance and coagulopathy, treated initially for sepsis, who progressed to neonatal acute liver failure and end‐stage hepatic encephalopathy after a prolonged hospitalization with extensive diagnostic evaluation, and was found by autopsy to have histopathologic ...
Adrienne Bruder   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy